213 related articles for article (PubMed ID: 8125143)
1. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay.
Stuber G; Leder GH; Storkus WT; Lotze MT; Modrow S; Székely L; Wolf H; Klein E; Kärre K; Klein G
Eur J Immunol; 1994 Mar; 24(3):765-8. PubMed ID: 8125143
[TBL] [Abstract][Full Text] [Related]
2. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.
Houbiers JG; Nijman HW; van der Burg SH; Drijfhout JW; Kenemans P; van de Velde CJ; Brand A; Momburg F; Kast WM; Melief CJ
Eur J Immunol; 1993 Sep; 23(9):2072-7. PubMed ID: 8370389
[TBL] [Abstract][Full Text] [Related]
3. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
[TBL] [Abstract][Full Text] [Related]
4. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Hoffmann TK; Donnenberg AD; Finkelstein SD; Donnenberg VS; Friebe-Hoffmann U; Myers EN; Appella E; DeLeo AB; Whiteside TL
Cancer Res; 2002 Jun; 62(12):3521-9. PubMed ID: 12067999
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides.
Nijman HW; Houbiers JG; van der Burg SH; Vierboom MP; Kenemans P; Kast WM; Melief CJ
J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):121-6. PubMed ID: 7506574
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides.
Bertholet S; Iggo R; Corradin G
Eur J Immunol; 1997 Mar; 27(3):798-801. PubMed ID: 9079825
[TBL] [Abstract][Full Text] [Related]
7. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
8. Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules.
Gnjatic S; Bressac-de Paillerets B; Guillet JG; Choppin J
Eur J Immunol; 1995 Jun; 25(6):1638-42. PubMed ID: 7542198
[TBL] [Abstract][Full Text] [Related]
9. The use of transgenic mice to generate high affinity p53 specific cytolytic T cells.
Yu Z; Liu X; McCarty TM; Diamond DJ; Ellenhorn JD
J Surg Res; 1997 May; 69(2):337-43. PubMed ID: 9224403
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
11. Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells.
Tokunaga N; Murakami T; Endo Y; Nishizaki M; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2005 Feb; 11(3):1312-8. PubMed ID: 15709203
[TBL] [Abstract][Full Text] [Related]
12. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB
Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724
[TBL] [Abstract][Full Text] [Related]
13. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes.
Slingluff CL; Cox AL; Henderson RA; Hunt DF; Engelhard VH
J Immunol; 1993 Apr; 150(7):2955-63. PubMed ID: 7681084
[TBL] [Abstract][Full Text] [Related]
14. Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum.
Blum-Tirouvanziam U; Servis C; Habluetzel A; Valmori D; Men Y; Esposito F; Del Nero L; Holmes N; Fasel N; Corradin G
J Immunol; 1995 Apr; 154(8):3922-31. PubMed ID: 7535817
[TBL] [Abstract][Full Text] [Related]
15. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM
Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681
[TBL] [Abstract][Full Text] [Related]
16. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H
Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253
[TBL] [Abstract][Full Text] [Related]
17. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
[TBL] [Abstract][Full Text] [Related]
18. Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes.
Sundar K; Boesen A; Coico R
Virology; 2007 Apr; 360(2):257-63. PubMed ID: 17123567
[TBL] [Abstract][Full Text] [Related]
19. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.
Guichard G; Connan F; Graff R; Ostankovitch M; Muller S; Guillet JG; Choppin J; Briand JP
J Med Chem; 1996 May; 39(10):2030-9. PubMed ID: 8642561
[TBL] [Abstract][Full Text] [Related]
20. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.
Wei ML; Cresswell P
Nature; 1992 Apr; 356(6368):443-6. PubMed ID: 1557127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
